相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
Cristina Tassorelli et al.
CEPHALALGIA (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Clinical features of migraine aura: Results from a prospective diary-aided study
Michele Viana et al.
CEPHALALGIA (2017)
Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study
Richard B. Lipton et al.
HEADACHE (2017)
Patients' preferences for headache acute and preventive treatment
Dimos D. Mitsikostas et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Variability of clinical features in attacks of migraine with aura
Jakob M. Hansen et al.
CEPHALALGIA (2016)
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
Tiffini Voss et al.
CEPHALALGIA (2016)
Network meta-analysis of migraine disorder treatment by NSAIDs and triptans
Haiyang Xu et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Random guess and wishful thinking are the best blinding scenarios
Heejung Bang
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2016)
Menstrual versus non-menstrual attacks of migraine without aura in women with and without menstrual migraine
Kjersti Grotta Vetvik et al.
CEPHALALGIA (2015)
'Visual snow' - a disorder distinct from persistent migraine aura
Christoph J. Schankin et al.
BRAIN (2014)
Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study
Mary Almas et al.
CEPHALALGIA (2014)
Comparative efficacy of triptans for the abortive treatment of migraine: A multiple treatment comparison meta-analysis
Kristian Thorlund et al.
CEPHALALGIA (2014)
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus et al.
CEPHALALGIA (2014)
The placebo-nocebo response: Controversies and challenges from clinical and research perspective
Miro Jakovljevic
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
A review of frovatriptan for the treatment of menstrual migraine
E. Anne MacGregor
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2014)
Early dosing and efficacy of triptans in acute migraine treatment: the TEMPO study
M. Lanteri-Minet et al.
CEPHALALGIA (2012)
Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators
Peer Tfelt-Hansen et al.
CEPHALALGIA (2012)
Reporting of Noninferiority and Equivalence Randomized Trials Extension of the CONSORT 2010 Statement
Gilda Piaggio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Placebo and other psychological interactions in headache treatment
A. Autret et al.
JOURNAL OF HEADACHE AND PAIN (2012)
The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: A post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study
H. C. Diener et al.
CEPHALALGIA (2011)
Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache
B Aicher et al.
CEPHALALGIA (2011)
Total Migraine Freedom, a Potential Primary Endpoint to Assess Acute Treatment in Migraine: Comparison to the Current FDA Requirement Using the Complete Rizatriptan Study Database
Anthony J. Rodgers et al.
HEADACHE (2011)
Random effects models in clinical research
T.J. Cleophas et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine
Lidia Savi et al.
JOURNAL OF HEADACHE AND PAIN (2011)
CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
INTERNATIONAL JOURNAL OF SURGERY (2011)
Randomized double-blind comparison of tolfenamic acid and paracetamol in migraine
B. H. Larsen et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
Kenneth F. Schulz et al.
ANNALS OF INTERNAL MEDICINE (2010)
Design considerations in migraine with aura trials: Learning from experience
Elizabeth Loder
CEPHALALGIA (2010)
Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial
Michel D. Ferrari et al.
CEPHALALGIA (2010)
On the methodology of drug trials in migraine with aura
Anne Werner Hauge et al.
CEPHALALGIA (2010)
Triptans for the Management of Migraine
Mollie M. Johnston et al.
DRUGS (2010)
Early Responses in Randomized Clinical Trials of Triptans in Acute Migraine Treatment. Are They Clinically Relevant? A Comment
Peer Tfelt-Hansen
HEADACHE (2010)
A Prospective Comparison Between ICHD-II and Probability Menstrual Migraine Diagnostic Criteria
Dawn A. Marcus et al.
HEADACHE (2010)
Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study
Vincenzo Tullo et al.
NEUROLOGICAL SCIENCES (2010)
Modified intention to treat reporting in randomised controlled trials: systematic review
Iosief Abraha et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
MENU LABELING: KNOWLEDGE FOR A HEALTHIER AMERICA
Tamara Schulman
HARVARD JOURNAL ON LEGISLATION (2010)
Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover study
R. B. Lipton et al.
CEPHALALGIA (2009)
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Rizatriptan 10-mg ODT for Early Treatment of Migraine and Impact of Migraine Education on Treatment Response
Roger K. Cady et al.
HEADACHE (2009)
Clinical Relevance of Efficacy Endpoints in OTC Headache Trials
Lutz Pageler et al.
HEADACHE (2009)
Comparison between numerical rating scale and six-level verbal rating scale in cancer patients with pain: a preliminary report
Carla Ida Ripamonti et al.
SUPPORTIVE CARE IN CANCER (2009)
Early vs. non-early intervention in acute migraine - 'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan
P. J. Goadsby et al.
CEPHALALGIA (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Identification of negative predictors of pain-free response to triptans: Analysis of the eletriptan database
H-C Diener et al.
CEPHALALGIA (2008)
Patient preference for triptan formulations: A prospective study with zolmitriptan
Andrew Dowson et al.
HEADACHE (2007)
Gatekekeeping procedures with clinical trial applications
Alex Dmitrienko et al.
PHARMACEUTICAL STATISTICS (2007)
Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives
Alex Dmitrienko et al.
STATISTICS IN MEDICINE (2007)
The natural course of migraine attacks.: A prospective analysis of untreated attacks compared with attacks treated with a triptan
M Linde et al.
CEPHALALGIA (2006)
Treatment strategies in the acute therapy of migraine: stratified care and early intervention
D. D'Amico et al.
NEUROLOGICAL SCIENCES (2006)
Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine
MJA Láinez et al.
CEPHALALGIA (2006)
Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life
RB Lipton et al.
NEUROLOGY (2005)
Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: A pooled analysis of data from six clinical trials
P Winner et al.
CLINICAL THERAPEUTICS (2005)
Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing
JL Brandes et al.
CEPHALALGIA (2005)
Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice
HC Diener
HEADACHE (2005)
Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo-controlled trial
E Loder et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls
E Loder et al.
CEPHALALGIA (2005)
Assessment of blinding in clinical trials
HJ Bang et al.
CONTROLLED CLINICAL TRIALS (2004)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres
F Granella et al.
CEPHALALGIA (2004)
Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild
J Klapper et al.
CEPHALALGIA (2004)
No effect of eletriptan administration during the aura phase of migraine
J Olesen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Tolerability and safety of eletriptan in the treatment of migraine: A comprehensive review
NT Mathew et al.
HEADACHE (2003)
Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: A multicenter, double-blind, placebo-controlled study conducted in the united states
F Sheftell et al.
HEADACHE (2003)
Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg
NT Mathew et al.
HEADACHE (2003)
Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine
S Christie et al.
EUROPEAN NEUROLOGY (2003)
Sum of Pain Intensity Differences (SPID) in migraine trials. A comment based on four rizatriptan trials
P Tfelt-Hansen et al.
CEPHALALGIA (2002)
Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials
MD Ferrari et al.
CEPHALALGIA (2002)
What do patients with migraine want from acute migraine treatment?
RB Lipton et al.
HEADACHE (2002)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:: a meta-analysis of 53 trials
MD Ferrari et al.
LANCET (2001)
Selective seratonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine:: a randomised controlled trial
DJ Goldstein et al.
LANCET (2001)
Familial migraine with and without aura:: clinical characteristics and co-occurrence
M Kallela et al.
EUROPEAN JOURNAL OF NEUROLOGY (2001)
A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients
CR Lines et al.
PAIN (2001)
Triptans in migraine - A comparative review of pharmacology, pharmacokinetics and efficacy
P Tfelt-Hansen et al.
DRUGS (2000)
Menstrual cycle and headache in a population sample of migraineurs
WF Stewart et al.
NEUROLOGY (2000)
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
SD Silberstein
NEUROLOGY (2000)
Migraine, quality of life, and depression - A population-based case-control study
RB Lipton et al.
NEUROLOGY (2000)
Determinants of patient satisfaction with migraine therapy
GM Davies et al.
CEPHALALGIA (2000)
Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine
J Pascual et al.
CEPHALALGIA (2000)
分享论文
